Study protocol for virtual leisure investigating the effect of virtual reality-delivered stress reduction, entertainment and distraction on the use of coercion and need-based medication and patient satisfaction at a closed psychiatric intensive care unit - a mixed-methods pilot clinical trial.
Adult psychiatry
Anxiety disorders
PSYCHIATRY
Schizophrenia & psychotic disorders
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
22 09 2023
22 09 2023
Historique:
medline:
25
9
2023
pubmed:
23
9
2023
entrez:
22
9
2023
Statut:
epublish
Résumé
The environment at a psychiatric inpatient ward can lead to emotional distress and behavioural deviations in vulnerable individuals potentially resulting in conflicts, increased use of need-based medication and coercive actions, along with low satisfaction with treatment. To accommodate these challenges, recreational and entertaining interventions are recommended. The tested interventions have, however, shown varying effects and demand a high degree of planning and staff involvement while being difficult to adapt to individual needs. Virtual reality (VR) may help overcome these challenges. The study is a mixed-methods clinical trial with a target sample of 124 patients hospitalised at a closed psychiatric ward in the capital region of Denmark. Outcomes (eg, coercion, need-based medication and perceived stress) for a 12-month period where all patients are offered VR-based recreational experiences during their hospitalisation will be compared with outcomes for a 12-month period where VR is not offered. Feasibility and acceptability will be explored with qualitative interviews supplemented with non-participant observations and focus groups. The study began on 1 January 2023, and we expect to complete data collection by 31 December 2024. The study is registered at Danish Data Protection Agency (j.no P-2022-466) and is approved by the Committee on Health Research Ethics of the capital region of Denmark (j.no 22013313). All patients will be required to provide informed consent. Results from this study will be disseminated via peer-reviewed journals and congress/consortium presentations. NCT05654740.
Identifiants
pubmed: 37739476
pii: bmjopen-2022-070566
doi: 10.1136/bmjopen-2022-070566
pmc: PMC10533807
doi:
Banques de données
ClinicalTrials.gov
['NCT05654740']
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e070566Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: SB is president and part owner of In Virtuo, a company that distributes virtual environments (although not those used in the current study), and conflict of interests are managed under UQO’s conflict of interest policy. No other authors declare competing interests.
Références
Front Psychol. 2019 Mar 12;10:479
pubmed: 30914996
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
PLoS One. 2017 Nov 22;12(11):e0187777
pubmed: 29166665
Int J Nurs Stud. 2015 Sep;52(9):1412-22
pubmed: 26166187
J Psychiatr Ment Health Nurs. 2014 Aug;21(6):499-508
pubmed: 24548312
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Nord J Psychiatry. 2012 Oct;66(5):297-302
pubmed: 22087631
Games Health J. 2016 Jun;5(3):197-202
pubmed: 27171578
Internet Interv. 2021 Jul 17;25:100432
pubmed: 34401391
Acta Psychiatr Scand Suppl. 2002;(412):103-5
pubmed: 12072138
Trials. 2017 Sep 29;18(1):445
pubmed: 28962668
Int J Ment Health Nurs. 2017 Oct;26(5):461-471
pubmed: 28960739
Psychol Med. 2018 Feb;48(3):362-391
pubmed: 28735593
Front Psychiatry. 2019 Jul 19;10:505
pubmed: 31379623
J Med Internet Res. 2021 Jan 15;23(1):e17233
pubmed: 33448933
BJPsych Open. 2021 Apr 16;7(3):e80
pubmed: 33858560
Lancet Psychiatry. 2018 Mar;5(3):217-226
pubmed: 29429948
Int J Qual Stud Health Well-being. 2016 Jan 22;11:29897
pubmed: 26806313
Arch Phys Med Rehabil. 2007 Dec;88(12 Suppl 2):S43-9
pubmed: 18036981
Psychol Med. 2017 Oct;47(14):2393-2400
pubmed: 28325167
Int J Soc Psychiatry. 2010 Jul;56(4):412-23
pubmed: 19617275
Anesth Analg. 2019 Nov;129(5):1344-1353
pubmed: 31136330
JMIR Form Res. 2021 Feb 3;5(2):e22406
pubmed: 33533720
Explore (NY). 2023 May-Jun;19(3):310-318
pubmed: 36002363
Eval Program Plann. 1979;2(3):197-207
pubmed: 10245370